|
"brett smith h"的相關文件
顯示項目 1-5 / 5 (共1頁)
1
每頁顯示[10|25|50]項目
| 國立成功大學 |
2009-11 |
Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naive HBeAg-positive patients with chronic hepatitis B
|
Chang, Ting-Tsung; Chao, Y. C.; Gorbakov, V. V.; Han, K. H.; Gish, R. G.; de Man, R.; Cheinquer, H.; Bessone, F.; Brett-Smith, H.; Tamez, R. |
| 國立成功大學 |
2009 |
Loss of HBsAg Antigen During Treatment With Entecavir in Nucleoside-na�ve HBeAg-positive Patients With Chronic Hepatitis B
|
Gish, R.; Chang, Ting-Tsung; Lai, C. L.; Man, R.; Gadano, A.; Poordad, F.; Yang, J.; Tamez, R.; Brett Smith H. |
| 國立成功大學 |
2006-10 |
Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
|
Sollano, J.; De Man, R. A.; Mutimer, D.; Gish, R. G.; Chang, Ting-Tsung; Zhu, J.; Cross, A.; Brett-Smith, H. |
| 國立成功大學 |
2006-10 |
Entecavir (ETV) treatment through 96 weeks results in virologic and biochemical improvement in HBeAg(-) chronic hepatitis B patients (study ETV-027)
|
Akarca, U.; Hatzis, G.; Kitis, G.; Shouval, D.; Lai, C.; Cheinquer, H.; Chang, Ting-Tsung; Zink, R.; Zhu, J.; Brett-Smith, H. |
| 國立成功大學 |
2006-07 |
Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
|
De Man, R. A.; Mutimer, D.; Gish, R.; Chang, Ting-Tsung; Zhu, J.; Cross, A.; Brett-Smith, H. |
顯示項目 1-5 / 5 (共1頁)
1
每頁顯示[10|25|50]項目
|
